tiprankstipranks
Advertisement
Advertisement

DRTS Stock Latest News

Alpha Tau files $300M mixed securities shelf
The FlyAlpha Tau files $300M mixed securities shelf
4d ago
DRTS
Alpha Tau to Present Pooled Pancreatic Cancer Alpha DaRT Data at 2026 ASCO Meeting
PremiumCompany Announcements
Alpha Tau to Present Pooled Pancreatic Cancer Alpha DaRT Data at 2026 ASCO Meeting
5d ago
6K
DRTS
Alpha Tau gets FDA investigational device exemption supplement to IMPACT study
PremiumThe Fly
Alpha Tau gets FDA investigational device exemption supplement to IMPACT study
9d ago
DRTS
Alpha Tau Treats First European Pancreatic Cancer Patient With Alpha DaRT in ACAPELLA Trial
PremiumCompany Announcements
Alpha Tau Treats First European Pancreatic Cancer Patient With Alpha DaRT in ACAPELLA Trial
9d ago
6K
DRTS
Alpha Tau treats first patient in ACAPELLA trial
PremiumThe Fly
Alpha Tau treats first patient in ACAPELLA trial
9d ago
DRTS
Alpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data
PremiumCompany AnnouncementsAlpha Tau Wins First DDW Oral Slot for Alpha DaRT Pancreatic Cancer Data
1M ago
6K
DRTS
Alpha Tau is Firing on All Cylinders: Japan Approval, 5 US Trials, And Now Pancreatic Data Heads to DDW
Premium
TipRanks Newswire
Alpha Tau is Firing on All Cylinders: Japan Approval, 5 US Trials, And Now Pancreatic Data Heads to DDW
1M ago
DRTS
Alpha Tau price target raised to $9 from $7 at Citi
Premium
The Fly
Alpha Tau price target raised to $9 from $7 at Citi
2M ago
DRTS
Alpha Tau Medical: U.S. Trial Expansion, Japan Approval, and Manufacturing Scale-Up Support Buy Rating Despite Near-Term Losses
PremiumRatings
Alpha Tau Medical: U.S. Trial Expansion, Japan Approval, and Manufacturing Scale-Up Support Buy Rating Despite Near-Term Losses
2M ago
DRTS
Alpha Tau Posts Wider 2025 Loss as Japanese Approval and U.S. Trial Progress Mark Pivotal Year
PremiumCompany Announcements
Alpha Tau Posts Wider 2025 Loss as Japanese Approval and U.S. Trial Progress Mark Pivotal Year
2M ago
6K
DRTS
Alpha Tau downgraded to Neutral from Overweight at Piper Sandler
PremiumThe Fly
Alpha Tau downgraded to Neutral from Overweight at Piper Sandler
2M ago
DRTS
DRTS Earnings this Week: How Will it Perform?
PremiumPre-Earnings
DRTS Earnings this Week: How Will it Perform?
2M ago
DRTS
Alpha Tau Lands First International Approval as Japan Grants Marketing Clearance for Alpha DaRT (NASDAQ: DRTS)
PremiumTipRanks NewswireAlpha Tau Lands First International Approval as Japan Grants Marketing Clearance for Alpha DaRT (NASDAQ: DRTS)
2M ago
DRTS
Alpha Tau price target raised to $12 from $9 at H.C. Wainwright
Premium
The Fly
Alpha Tau price target raised to $12 from $9 at H.C. Wainwright
2M ago
DRTS
Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy
Premium
Company Announcements
Alpha Tau Wins First Overseas Approval as Japan Clears Alpha DaRT Cancer Therapy
2M ago
6K
DRTS
Alpha Tau announces Japan’s MHLW granted marketing approbal for Alpha DaRT
PremiumThe Fly
Alpha Tau announces Japan’s MHLW granted marketing approbal for Alpha DaRT
2M ago
DRTS
Alpha Tau Outlines Aggressive 2026 Clinical Schedule and Manufacturing Ramp for Alpha DaRT Cancer Therapy
PremiumCompany Announcements
Alpha Tau Outlines Aggressive 2026 Clinical Schedule and Manufacturing Ramp for Alpha DaRT Cancer Therapy
3M ago
6K
DRTS
Alpha Tau issues letter to shareholders
PremiumThe Fly
Alpha Tau issues letter to shareholders
3M ago
DRTS
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026
PremiumCompany Announcements
Alpha Tau Medical Unveils Strong Pancreatic Cancer Alpha DaRT Data Ahead of ASCO GI 2026
4M ago
6K
DRTS
Alpha Tau announces release of final results from study of Alpha DaRT
PremiumThe FlyAlpha Tau announces release of final results from study of Alpha DaRT
4M ago
DRTS
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical
Premium
Ratings
Advancing Alpha DaRT: Regulatory Momentum, Pipeline Expansion, and Favorable Risk–Reward Support Buy Rating on Alpha Tau Medical
4M ago
DRTS
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy
Premium
Company Announcements
Alpha Tau Files First FDA PMA Module for Alpha DaRT Skin Cancer Therapy
4M ago
6K
DRTS

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >